Drugs / modified allergen extract of house dust mites
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01013116 | Apr 2016 → Apr 2017 | allergic rhinitis | Roxall | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | modified allergen extract of house dust mites | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01013116 ↗ |
| Route | Subcutaneous | “subcutaneous injections” NCT01013116 ↗ |